Search by Drug Name or NDC
NDC 59651-0306-05 CHLORZOXAZONE 500 mg/1 Details
CHLORZOXAZONE 500 mg/1
CHLORZOXAZONE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is CHLORZOXAZONE.
MedlinePlus Drug Summary
Chlorzoxazone is used to relieve pain and stiffness caused by muscle strains and sprains. It is used in combination with physical therapy, analgesics (such as aspirin or acetaminophen), and rest.
Related Packages: 59651-0306-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Chlorzoxazone
Product Information
| NDC | 59651-0306 |
|---|---|
| Product ID | 59651-306_13956b60-a22d-4ee8-af95-460830ebfbc9 |
| Associated GPIs | 75100040000310 |
| GCN Sequence Number | 004660 |
| GCN Sequence Number Description | chlorzoxazone TABLET 500 MG ORAL |
| HIC3 | H6H |
| HIC3 Description | SKELETAL MUSCLE RELAXANTS |
| GCN | 17901 |
| HICL Sequence Number | 001941 |
| HICL Sequence Number Description | CHLORZOXAZONE |
| Brand/Generic | Generic |
| Proprietary Name | CHLORZOXAZONE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | CHLORZOXAZONE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 500 |
| Active Ingredient Units | mg/1 |
| Substance Name | CHLORZOXAZONE |
| Labeler Name | Aurobindo Pharma Limited |
| Pharmaceutical Class | Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA089853 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59651-0306-05 (59651030605)
| NDC Package Code | 59651-306-05 |
|---|---|
| Billing NDC | 59651030605 |
| Package | 500 TABLET in 1 BOTTLE (59651-306-05) |
| Marketing Start Date | 2020-08-03 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.23873 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | CHLORZOXAZONE 500 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis